Interventricular septal thickening as an early manifestation of cardiac sarcoidosis

International Heart Journal

Volumn 55, Issue 2, 2014, Pages 181-183

  Nureki, Shin Ichi ^a   Miyazaki, Eishi ^a   Nishio, Suehiro ^a   Ehara, Chihiro ^a   Yamasue, Mari ^a   Ando, Masaru ^a   Kadota, Jun Ichi ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Interventricular septum

Indexed keywords

CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE; GALLIUM 67; LYSOZYME; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PREDNISOLONE; STEROID;

ADULT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CASE REPORT; CRACKLE; DRUG DOSE REDUCTION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART INJURY; HEART PERFUSION; HEART VENTRICLE SEPTUM DEFECT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERVENTRICULAR SEPTAL THICKENING; KIDNEY BIOPSY; KIDNEY DYSFUNCTION; KIDNEY TUMOR; LUNG BIOPSY; PRIORITY JOURNAL; SARCOIDOSIS; SCINTIGRAPHY; SKIN BIOPSY; SYSTOLIC HEART MURMUR;

ADMINISTRATION, ORAL; CARDIOMYOPATHIES; DIAGNOSIS, DIFFERENTIAL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; GLUCOCORTICOIDS; HUMANS; HYPERTROPHY; MAGNETIC RESONANCE IMAGING, CINE; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; PREDNISOLONE; SARCOIDOSIS; VENTRICULAR SEPTUM;

EID: 84897080517     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.13-243     Document Type: Article

References (13)

1. Burstow DJ, Tajik AJ, Bailey KR, DeRemee RA, Taliercio CP. Two-dimensional echocardiographic findings in systemic sarcoidosis. Am J Cardiol 1989; 63: 478-82.
2. Yazaki Y, Isobe M, Hayasaka M, Tanaka M, Fujii T, Sekiguchi M. Cardiac sarcoidosis mimicking hypertrophic cardiomyopathy: clinical utility of radionuclide imaging for differential diagnosis. Jpn Circ J 1998; 62: 465-8.
3. Matsumori A, Hara M, Nagai S, et al. Hypertrophic cardiomyopathy as a manifestation of cardiac sarcoidosis. Jpn Circ J 2000; 64: 679-83.
4. Morimoto T, Azuma A, Abe S, et al. Epidemiology of sarcoidosis in Japan. Eur Respir J 2008; 31: 372-9.
5. Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 1978; 58: 1204-11.
6. Sekiguchi M, Yazaki Y, Isobe M, Hiroe M. Cardiac sarcoidosis: diagnostic, prognostic, and therapeutic considerations. Cardiovasc Drugs Ther 1996; 10: 495-510. (Review)
7. Yazaki Y, Isobe M, Hiroe M, et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 2001; 88: 1006-10.
8. Chiu CZ, Nakatani S, Zhang G, et al. Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis. Am J Cardiol 2005; 95: 143-6.
9. Matsui Y, Iwai K, Tachibana T, et al. Clinicopathological study of fatal myocardial sarcoidosis. Ann N Y Acad Sci 1976; 278: 455-69.
10. Dubrey SW, Falk RH. Diagnosis and management of cardiac sarcoidosis. Prog Cardiovasc Dis 2010; 52: 336-46. (Review)
11. Umetani K, Ishihara T, Yamamoto K, et al. Successfully treated complete atrioventricular block with corticosteroid in a patient with cardiac sarcoidosis: usefulness of gallium-67 and thallium- 201 scintigraphy. Intern Med 2000; 39: 245-8.
12. Miyazaki S, Funabashi N, Nagai T, et al. Cardiac sarcoidosis complicated with atrioventricular block and wall thinning, edema and fibrosis in left ventricle: confirmed recovery to normal sinus rhythm and visualization of edema improvement by administration of predonisolone. Int J Cardiol 2011; 150: e4-10.
13. Okamura H, Goto Y, Terashima M, Takagi S, Ishibashi-Ueda H, Nonogi H. Images in cardiovascular medicine. Reversible right ventricular hypertrophy due to cardiac sarcoidosis. Circulation 2005; 111: e383-4.